RBC Raises AstraZeneca Price Target to GBP152.50 From GBP145, Keeps Outperform
RBC raised its price target on AstraZeneca to GBP152.50 from GBP145 and maintained its Outperform rating.
RBC raised its price target on AstraZeneca to GBP152.50 from GBP145 and maintained its Outperform rating.